109 related articles for article (PubMed ID: 31243220)
1. Immunoglobulin Light Chain Amyloidosis with Severe Liver Dysfunction Accompanied by Factor X Deficiency.
Guo YM; Takahashi N; Miyabe K; Yoshida M; Abe F; Yamashita T; Nara M; Yoshioka T; Ohashi K; Goto A; Takahashi N
Intern Med; 2019 Oct; 58(20):3039-3043. PubMed ID: 31243220
[TBL] [Abstract][Full Text] [Related]
2. Acute deep vein thrombosis with concurrent new diagnosis of AL-amyloid-induced factor X deficiency.
Paton EL; Barisic S; Sabile JM; Medvedova E
BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38839408
[TBL] [Abstract][Full Text] [Related]
3. [AL Amyloidosis].
Ueda M
Brain Nerve; 2024 May; 76(5):583-587. PubMed ID: 38741500
[TBL] [Abstract][Full Text] [Related]
4. Peripheral Nervous, Hepatic, and Gastrointestinal Endpoints for AL Amyloidosis Clinical Trials: Report from the Amyloidosis Forum Multi-organ System Working Group.
Mauermann ML; Clarke JO; Litchy WJ; Obici L; Lousada I; Gertz MA;
Adv Ther; 2023 Nov; 40(11):4695-4710. PubMed ID: 37658177
[TBL] [Abstract][Full Text] [Related]
5. How I Approach Light Chain Amyloidosis.
Chowdhury RB; Leung N
G Ital Nefrol; 2023 Oct; 40(Suppl 81):. PubMed ID: 38007836
[TBL] [Abstract][Full Text] [Related]
6. Acute liver failure due to primary amyloidosis in a nephrotic syndrome: a swiftly progressive course.
Cardoso BA; Leal R; Sá H; Campos M
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26965175
[TBL] [Abstract][Full Text] [Related]
7. Intraoral hemorrhagic bullae as the first sign of immunoglobulin light chain amyloidosis.
Dominguez-Lopez RM; Naharro-Rodriguez J
CMAJ; 2024 May; 196(20):E705. PubMed ID: 38802132
[No Abstract] [Full Text] [Related]
8. Response of factor X deficiency to darutumumab in the treatment of AL amyloidosis: a novel finding.
Mar E; Taylor K; Mollee P
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33827877
[TBL] [Abstract][Full Text] [Related]
9. Thromboembolism and bleeding in systemic amyloidosis: a review.
Nicol M; Siguret V; Vergaro G; Aimo A; Emdin M; Dillinger JG; Baudet M; Cohen-Solal A; Villesuzanne C; Harel S; Royer B; Arnulf B; Logeart D
ESC Heart Fail; 2022 Feb; 9(1):11-20. PubMed ID: 34784656
[TBL] [Abstract][Full Text] [Related]
10. How well does liver span as part of the consensus criteria for liver involvement in AL amyloidosis perform?
Brunger AF; van Rheenen R; Gans ROB; Hazenberg BPC; Nienhuis HLA
Amyloid; 2023 Dec; 30(4):437-439. PubMed ID: 37318263
[No Abstract] [Full Text] [Related]
11. Acquired factor X deficiency in a multiple myeloma without amyloidosis: a case report.
Coussee A; Alliet G; Hervent AS; Vynckier L; Emmerechts J; Van Hecke S; Persijn L
Acta Clin Belg; 2023 Dec; 78(6):524-528. PubMed ID: 37800976
[TBL] [Abstract][Full Text] [Related]
12. Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis.
Ravichandran S; Law S; Mahmood S; Wisniowski B; Foard D; Fontana M; Martinez-Naharro A; Whelan C; Gillmore JD; Lachmann HJ; Hawkins PN; Wechalekar AD
Leukemia; 2022 Apr; 36(4):1180-1184. PubMed ID: 34987193
[No Abstract] [Full Text] [Related]
13. Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients.
Thompson CA; Kyle R; Gertz M; Heit J; Pruthi R; Pardanani A
Am J Hematol; 2010 Mar; 85(3):171-3. PubMed ID: 20052750
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for a patient with liver failure combined with liver amyloidosis and coagulation factor X deficiency.
Yang H; Zhang P; Wang Q; Zhao Y
Asian J Surg; 2024 Jun; 47(6):2956-2957. PubMed ID: 38493030
[No Abstract] [Full Text] [Related]
15. Missed opportunity for anticoagulation in a patient with AL cardiac amyloidosis and rapidly progressive heart failure.
Avula SR; Handa R; Balakrishnan B; Girard S
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28784887
[TBL] [Abstract][Full Text] [Related]
16. Chinese consensus on the diagnosis and treatment of immunoglobulin light-chain cardiac amyloidosis.
Shen K; Tian Z; Gao Y; Wang Y; Huo L; Li J; Zhang Y; Zhang S;
Chin Med J (Engl); 2024 Jan; 137(2):127-129. PubMed ID: 38146261
[No Abstract] [Full Text] [Related]
17. An unusual case of AL amyloidosis presenting as alopecia and nail changes.
Bnaya A; Tvito A; Ben-Chetrit E; Shavit L; Breuer GS
Intern Emerg Med; 2023 Oct; 18(7):2133-2134. PubMed ID: 37086347
[No Abstract] [Full Text] [Related]
18. Endoscopic Manifestations and Clinical Characteristics of Localized Gastric Light-Chain Amyloidosis.
Iwamuro M; Tanaka S; Toyokawa T; Nishimura M; Tsuzuki T; Miyahara K; Negishi S; Ohya S; Tanaka T; Otsuka M
Acta Med Okayama; 2023 Oct; 77(5):545-552. PubMed ID: 37899266
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic and bleeding complications in patients with AL amyloidosis.
Fotiou D; Theodorakakou F; Spiliopoulou S; Gavriatopoulou M; Migkou M; Kanellias N; Eleutherakis-Papaiakovou E; Malandrakis P; Dialoupi I; Roussou M; Ntanasis-Stathopoulos I; Terpos E; Dimopoulos MA; Kastritis E
Br J Haematol; 2024 May; 204(5):1816-1824. PubMed ID: 38321638
[TBL] [Abstract][Full Text] [Related]
20. Cardiac AL amyloidosis presenting as recurrent dyspnoea in a patient with cancer: an important clinical clue to an early diagnosis.
Suero-Abreu GA; Lim P; Patel B; Thomas R
BMJ Case Rep; 2022 Sep; 15(9):. PubMed ID: 37209004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
